Proteasome Inhibitor [EPC]

114624 reported adverse events

Drugs of this class: BORTEZOMIB CARFILZOMIB

These side effects are most commonly reported by patients taking drugs of the Proteasome Inhibitor [EPC] class:

# Side effect Count
0 PLASMA CELL MYELOMA 11145
1 OFF LABEL USE 8563
2 NEUROPATHY PERIPHERAL 7016
3 DIARRHOEA 6185
4 FATIGUE 5924
5 DEATH 5717
6 PNEUMONIA 5273
7 THROMBOCYTOPENIA 4996
8 DRUG INEFFECTIVE 4259
9 NAUSEA 4079
See all common reactions for Proteasome Inhibitor [EPC]

Drugs of the Proteasome Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLASMA CELL MYELOMA REFRACTORY 919 0.6868
1 PLASMA CELL LEUKAEMIA 288 0.4800
2 PLASMA CELL MYELOMA RECURRENT 1479 0.4549
3 PLASMACYTOMA 624 0.3349
4 PLASMA CELL MYELOMA 11145 0.2854
5 MULTIPLE MYELOMA 681 0.1460
6 STEM CELL TRANSPLANT 305 0.1220
7 POLYNEUROPATHY 1190 0.0993
8 PERIPHERAL SENSORY NEUROPATHY 457 0.0781
9 TUMOUR LYSIS SYNDROME 659 0.0748
See all enriched reactions for Proteasome Inhibitor [EPC]